Single-agent rituximab for treatment of multifocal and multiple relapsed pulmonary inflammatory myofibroblastic tumor in an adolescent patient

Pediatr Blood Cancer. 2021 Sep;68(9):e29131. doi: 10.1002/pbc.29131. Epub 2021 Jun 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Humans
  • Lung Neoplasms / drug therapy*
  • Neoplasms, Muscle Tissue / drug therapy*
  • Recurrence
  • Rituximab / therapeutic use*

Substances

  • Rituximab